Voglibose
- Iupac Name:(1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol
- CAS No.: 83480-29-9
- Molecular Weight:267.278
- Modify Date.: 2022-11-29 06:02
- Introduction: 1. It is used for treating diabetes.2. Anti-diabetic drug.
View more+
1. Names and Identifiers
- 1.1 Name
- Voglibose
- 1.2 Synonyms
(1S,2S,3R,4S,5S)-5-((1,3-Dihydroxypropan-2-yl)amino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol (1S,2S,3R,4S,5S)-5-[(1,3-Dihydroxypropan-2-yl)amino]-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol 2,3-Dideoxy-2-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-4-C-(hydroxymethyl)-epi-inositol 3,4-Dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-C-(hydroxymethyl)-D-epi-inositol 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol A 71100 AO 128 Basen Beigrace D-epi-Inositol, 3,4-dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-C-(hydroxymethyl)- epi-Inositol, 2,3-dideoxy-2-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-4-C-(hydroxymethyl)- Glustat Jumeal N-(1,3-Dihydroxy-2-propyl)valiolamine N-(1,3-Dihydroxyprop-2-yl)valiolamine Voglistat
- 1.3 CAS No.
- 83480-29-9
- 1.4 CID
- 444020
- 1.5 EINECS(EC#)
- 1312995-182-4
- 1.6 Molecular Formula
- C10H21NO7 (isomer)
- 1.7 Inchi
- InChI=1S/C10H21NO7/c12-2-5(3-13)11-6-1-10(18,4-14)9(17)8(16)7(6)15/h5-9,11-18H,1-4H2/t6-,7-,8+,9-,10-/m0/s1
- 1.8 InChkey
- FZNCGRZWXLXZSZ-CIQUZCHMSA-N
- 1.9 Canonical Smiles
- C1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO
- 1.10 Isomers Smiles
- C1[C@@H]([C@@H]([C@H]([C@@H]([C@]1(CO)O)O)O)O)NC(CO)CO
2. Properties
- 2.1 Density
- 1.58
- 2.1 Melting point
- 162-163℃
- 2.1 Boiling point
- 601.9oC at 760 mmHg
- 2.1 Refractive index
- 1.635
- 2.1 Flash Point
- 274.1oC
- 2.1 Precise Quality
- 267.13200
- 2.1 PSA
- 153.64000
- 2.1 logP
- -4.10150
- 2.1 Appearance
- Solid
- 2.2 Storage
- Store at -20°C
- 2.3 Chemical Properties
- Colourless Crystalline Solid
- 2.4 Physical
- Solid
- 2.5 pKa
- 13.26±0.70(Predicted)
- 2.6 Water Solubility
- 1.90e+02 g/L
- 2.7 StorageTemp
- Store in original container in a cool dark place.
3. Use and Manufacturing
- 3.1 Methods of Manufacturing
- III (0.2 g, 0.001 mmol) was added to DMF (8 mL), stirred and dissolved, followed by the addition of 1, 3-dihydroxyacetone (0.3 g, 0.03 mmol), 2N HCl (0.15 mL) and NaBH3CN (0.22 g, 0.004 mol) at 60 °C for 24 h cooled to room temperature, add water (3mL), adjusted to pH=4.0 with 2 Ν HCl, stirred for 30min, 1N NaOH was added to adjust PH = 7.0, the solvent was distilled off under reduced pressure through the UBK resin, followed by elution with water, 2N ammonia, and the eluate was collected and concentrated. After passing through CG50, water: ethanol (6: 4) was eluted and the eluate was collected, and then decolorized by Dowex1 x 2 to give 0.24 g of white powder voglibose, 85percent.To a solution of 6 (483mg, 2.5mmol) in DMF (30mL), 1, 3-dihydroxyacetone (900mg, 10.0mmol) and 2.0M hydrochloric acid (0.50mL) and NaBHThe synthesis of voglibose from the starting material, d-glucose, to compound 1 referred to the previous reports.
- 3.2 Usage
- 1. It is used for treating diabetes.2. Anti-diabetic drug.
4. Safety and Handling
- 4.1 Hazard Codes
- Xi
- 4.1 Risk Statements
- R20/21/22
- 4.1 Safety Statements
- S36/37
- 4.1 RIDADR
- HAZARD
- 4.1 WGK Germany
- 3
- 4.1 RTECS
- NM7524600
- 4.1 Safety
-
Hazard Codes:?
Xi
Risk Statements: 20/21/22-36/37/38?
R20/21/22: Harmful by inhalation, in contact with skin and if swallowed
R36/37/38: Irritating to eyes, respiratory system and skin
Safety Statements: 36/37-37/39-26?
S36/37: Wear suitable protective clothing and gloves
S37/39: Wear suitable gloves and eye/face protection
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
RTECS: NM7524600
- 4.2 Specification
-
?Voglibose?(CAS NO.83480-29-9) is also called as?Voglibose [USAN:INN]?; 3,4-Dideoxy-4-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-2-C-(hydroxymethyl)-D-epi-inositol ; Voglibosa ; Voglibosa [INN-Spanish] ; Voglibose ; Voglibosum ; Voglibosum [INN-Latin] ; 3,4-Dideoxy-4-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-2-C-(hydroxymethyl)-D-epi-inositol .There are three molecules which belong to this class namely, Acarbose, Miglitol and Voglibose?(CAS NO.83480-29-9). Voglibose?(CAS NO.83480-29-9) is the latest molecule in this class. Voglibose?(CAS NO.83480-29-9) scores over both Acarbose and MIglitol in terms of side effect profile. But Acarbose has an edge over Voglibose?(CAS NO.83480-29-9) in terms of efficacy(FBG , PPBG , HBA1C).
- 4.3 Toxicity
-
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
dog |
LD50 |
oral |
> 2gm/kg (2000mg/kg) |
? |
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 25, Pg. 815, 1994. |
mouse |
LD50 |
intravenous |
7820mg/kg (7820mg/kg) |
? |
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 25, Pg. 815, 1994. |
mouse |
LD50 |
oral |
14700mg/kg (14700mg/kg) |
? |
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 25, Pg. 815, 1994. |
rat |
LD50 |
intravenous |
6300mg/kg (6300mg/kg) |
? |
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 25, Pg. 815, 1994. |
rat |
LD50 |
oral |
20gm/kg (20000mg/kg) |
? |
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 25, Pg. 815, 1994. |
5. MSDS
2.Hazard identification
2.1 Classification of the substance or mixture
no data available
2.2 GHS label elements, including precautionary statements
Pictogram(s) | no data available |
Signal word | no data available |
Hazard statement(s) | no data available |
Precautionary statement(s) | |
Prevention | no data available |
Response | no data available |
Storage | no data available |
Disposal | no data available |
2.3 Other hazards which do not result in classification
no data available
7. Synthesis Route
83480-29-9Total: 4 Synthesis Route
9. Other Information
- 9.0 Storage Conditions
- III (0.2 g, 0.001 mmol) was added to DMF (8 mL), stirred and dissolved, followed by the addition of 1, 3-dihydroxyacetone (0.3 g, 0.03 mmol), 2N HCl (0.15 mL) and NaBH3CN (0.22 g, 0.004 mol) at 60 °C for 24 h cooled to room temperature, add water (3mL), adjusted to pH=4.0 with 2 Ν HCl, stirred for 30min, 1N NaOH was added to adjust PH = 7.0, the solvent was distilled off under reduced pressure through the UBK resin, followed by elution with water, 2N ammonia, and the eluate was collected and concentrated. After passing through CG50, water: ethanol (6: 4) was eluted and the eluate was collected, and then decolorized by Dowex1 x 2 to give 0.24 g of white powder voglibose, 85percent.To a solution of 6 (483mg, 2.5mmol) in DMF (30mL), 1, 3-dihydroxyacetone (900mg, 10.0mmol) and 2.0M hydrochloric acid (0.50mL) and NaBHThe synthesis of voglibose from the starting material, d-glucose, to compound 1 referred to the previous reports.
- 9.1 Mesh
- Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)|Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES. (See all compounds classified as Glycoside Hydrolase Inhibitors.)
- 9.2 Absorption
- Slowly and poorly absorbed. The reported pharmacokinetic parameters of voglibose with metformin are Cmax corresponds to 1.38 mcg/ml while AUC is 8.17 mcg.h/ml and tmax is of 2.5 hours.
- 9.3 Metabolism
- Little metabolism occurs and no metabolites have as yet been identified.
- 9.4 Biological Half Life
- The half-life of voglibose is very similar to the one found for metformin and it is reported to be of 4.08 hours.
- 9.5 Mesh Entry Terms
- 3,4-dideoxy-4-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-2-C-(hydroxymethyl)-D-epi-inositol
10. Computational chemical data
- Molecular Weight: 267.278g/mol
- Molecular Formula: C10H21NO7
- Compound Is Canonicalized: True
- XLogP3-AA: -4.1
- Exact Mass: 267.13180201
- Monoisotopic Mass: 267.13180201
- Complexity: 263
- Rotatable Bond Count: 5
- Hydrogen Bond Donor Count: 8
- Hydrogen Bond Acceptor Count: 8
- Topological Polar Surface Area: 154
- Heavy Atom Count: 18
- Defined Atom Stereocenter Count: 5
- Undefined Atom Stereocenter Count: 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Isotope Atom Count: 0
- Covalently-Bonded Unit Count: 1
- CACTVS Substructure Key Fingerprint: AAADceByOAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAAAAAAAHgAQCAAADHzhgAYAAALAAgAAAAAAAAAAAAAAAAAAAIAIAAADEAIAgAAEQAAHEACRAAHw8DcOAAAAAAAAAABCgAKUABCgAAAAAAAAAA==
11. Question & Answer
-
Description Voglibose (INN and USAN, trade name Voglib, marketed by Mascot Health Series) is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. Voglibose delays the absorption of glucose thereby reducing the risk of macrovascular co...
12. Recommended Suppliers
-
- Products:PMK ethyl glycidate,28578-16-7 ,bmk,5449-12-7,71368-80-4,bromazolam
- Tel:0371-60331257-+86
- Email:henan2@yuanlongbio.com
-
- Products:Cosmetic Raw Materials,solvents,etc.
- Tel:86-311-66562153
- Email:breeduan@crovellbio.com
-
- Products:pmk powder ;pmk oil ;bmk powder ;bmk oil ;Protonitazene hcl ; Bromazolam ; Metonitazene; 2-Bromo-4'-methylpropiophenone ;
- Tel:+86-131-71569950
- Email:dree@chbbest.com
-
- Products:Division I, the main production Lead acetate phenylacetamide Cyromazine quality is very good!
- Tel:86-185-31123677
- Email:xing@yan-xi.com
-
- Products:Manufacture & Supply Biopharm Chemical, Specialty Chemical, PetroChemical.
- Tel:86-592-8883942
- Email:sale@amitychem.com
13. Realated Product Infomation